Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma and prior anti-tumor therapy: A subanalysis from the sharp trial

被引：9
|
作者：
Galle, P. [1 ]
Blanc, J. [2 ]
Van Laethem, J-L. [3 ]
Marrero, J. [4 ]
Beaugrand, M. [5 ]
Moscovici, M. [6 ]
Shan, M. [7 ]
Nadel, A. [7 ]
Voliotis, D. [8 ]
Bruix, J. [9 ]
Llovet, J. M. [9 ,10 ]
机构：
[1] Univ Mainz Klinikum, Mainz, Germany
[2] CHU, Hop St Andre, Bordeaux, France
[3] Erasme Univ Hosp, B-1070 Brussels, Belgium
[4] Univ Michigan, Ann Arbor, MI 48109 USA
[5] Hop Jean Verdier, Bondy, France
[6] Bayer Schering Pharma, Milan, Italy
[7] Bayer Healthcare Pharmaceut, West Haven, CT USA
[8] Bayer Schering Pharma, Global Clin Dev, Wuppertal, Germany
[9] Hosp Clin Barcelona, Liver Unit, CIBERehd, IDIBAPS,BCLC Grp, Barcelona, Spain
[10] Mt Sinai Sch Med, Div Liver Dis, New York, NY USA
来源：
JOURNAL OF HEPATOLOGY | 2008年 / 48卷
关键词：
D O I：
10.1016/S0168-8278(08)60996-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
994
引用
收藏
页码：S372 / S372
页数：1
相关论文
共 50 条
  • [41] Safety and Efficacy of Sorafenib in Patients With Advanced Hepatocellular Carcinoma in Consideration of Concomitant Stage of Liver Cirrhosis
    Woerns, Marcus Alexander
    Weinmann, Arndt
    Pfingst, Kerstin
    Schulte-Sasse, Carla
    Messow, Claudia-Martina
    Schulze-Bergkamen, Henning
    Teufel, Andreas
    Schuchmann, Marcus
    Kanzler, Stephan
    Dueber, Christoph
    Otto, Gerd
    Galle, Peter Robert
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2009, 43 (05) : 489 - 495
  • [42] Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis
    Federico, Alessandro
    Orditura, Michele
    Cotticelli, Gaetano
    De Sio, Ilario
    Romano, Marco
    Gravina, Antonietta Gerarda
    Dallio, Marcello
    Fabozzi, Alessio
    Ciardiello, Fortunato
    Loguercio, Carmela
    De Vita, Ferdinando
    ONCOLOGY LETTERS, 2015, 9 (04) : 1628 - 1632
  • [43] Efficacy and safety of nivolumab in asian patients with advanced hepatocellular carcinoma (HCC): Subanalysis of the CheckMate 040 Study
    Choo, S. P.
    Yau, T.
    Hsu, C.
    Kang, Y-K.
    Hou, M-M.
    Yeo, W.
    Numata, K.
    Chopra, A.
    Baakili, A.
    Dela Cruz, C.
    Zhao, H.
    Kudo, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [44] Efficacy and safety of regorafenib after progression on sorafenib in Korean patients with advanced hepatocellular carcinoma (HCC)
    Yoo, C.
    Park, J-W.
    Kim, Y. J.
    Kim, D. Y.
    Yu, S. J.
    Lim, T. S.
    Ryoo, B-Y.
    Lee, S. J.
    Lim, H-Y.
    ANNALS OF ONCOLOGY, 2018, 29
  • [45] SYNERGISTIC ANTI-TUMOR EFFECT OF SORAFENIB IN COMBINATION WITH AKT INHIBITORS IN HEPATOCELLULAR CARCINOMA
    Feng, W. -C.
    Hsu, C. -H.
    Lin, S. -D.
    Lin, H. -H.
    Hsu, D. -W.
    Huang, C. -C.
    Chow, L. -P.
    Cheng, A. -L.
    ANNALS OF ONCOLOGY, 2012, 23 : 16 - 16
  • [46] Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma
    Ou, Da-Liang
    Chang, Chun-Jung
    Jeng, Yung-Ming
    Lin, Yi-Jang
    Lin, Zhong-Zhe
    Gandhi, Anita K.
    Liao, Sheng-Chieh
    Huang, Zi-Ming
    Hsu, Chiun
    Cheng, Ann-Lii
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (12) : 2021 - 2031
  • [47] Efficacy and Prognostic Factors of Sorafenib Targeted Therapy for Advanced Hepatocellular Carcinoma
    Sun Long
    Yang Shiwei
    Fang Qing
    Liu Ping
    Zhang Rongjie
    Hu Chunfang
    Hao Yingxue
    LATIN AMERICAN JOURNAL OF PHARMACY, 2021, 40 (01): : 120 - 125
  • [48] Efficacy and safety of nintedanib versus sorafenib in Asian patients with advanced hepatocellular carcinoma (HCC): A randomized phase II trial.
    Cheng, Ann-Lii
    Yen, Chia-Jui
    Kim, Tae-You
    Feng, Yin-Hsun
    Chao, Yee
    Lin, Deng-Yn
    Loembe, Arsene-Bienvenu
    Hocke, Julia
    Choi, Caren
    Ryoo, Baek-Yeol
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [49] Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia-Pacific trial
    Cheng, Ann-Lii
    Guan, Zhongzhen
    Chen, Zhendong
    Tsao, Chao-Jung
    Qin, Shukui
    Kim, Jun Suk
    Yang, Tsai-Sheng
    Tak, Won Young
    Pan, Hongming
    Yu, Shiying
    Xu, Jianming
    Fang, Fang
    Zou, Jessie
    Lentini, Giuseppe
    Voliotis, Dimitris
    Kang, Yoon-Koo
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (10) : 1452 - 1465
  • [50] Efficacy and Safety of Sorafenib in a Racially Diverse Patient Population with Advanced Hepatocellular Carcinoma
    Schmidt, Timothy M.
    Liu, Li
    Abraham, Ivy E.
    Uy, Almae B.
    Dudek, Arkadiusz Z.
    ANTICANCER RESEARCH, 2018, 38 (07) : 4027 - 4034
12345